Phylo Partners With Bayer on Biomni Lab AI Agents for Drug Research

Phylo has partnered with Bayer to provide full access to its Biomni Lab agentic AI platform, aiming to accelerate drug discovery by integrating literature and omics data workflows. The platform enables Bayer scientists to efficiently assemble and assess biomedical evidence while maintaining transparency and scientific rigor.